Location History:
- Rockaway Township, NJ (US) (1976 - 1977)
- Rockaway, NJ (US) (1976 - 1978)
- Rockaway Township, Morris County, NJ (US) (1977 - 1978)
- New Castle, DE (US) (1978 - 1982)
Company Filing History:
25 out of 2,538 
1 out of 832,880 Years Active: 1976-1982
Title: Maximilian VON Strandtmann: A Talented Inventor from Rockaway Township, NJ
Introduction:
Maximilian VON Strandtmann, hailing from Rockaway Township, NJ, is a highly accomplished inventor with an impressive portfolio of 20 patents. His innovative creations have made a significant impact in various fields, particularly in the domain of pharmaceuticals. Let us delve into some of his latest patents, career highlights, notable collaborations, and conclude by acknowledging his valuable contributions to the world of inventions.
Latest Patents:
1. 1-Nor-2-amino carbamates derived from acid S, an antibiotic produced by Polyangium cellulosum var. fulvum:
VON Strandtmann's patent is centered around 1-nor-2-amino carbamates derived from a highly significant antibiotic substance known as acid S, produced by Polyangium cellulosum var. fulvum (ATCC No. 25532). These compounds have shown promise as potent antifungal agents, introducing a new avenue in the fight against fungal infections.
2. 1-Substituted-2-(2-pyridinyl)ethanone N-oxides:
Another noteworthy patent by VON Strandtmann involves 1-Substituted-2-(2-pyridinyl)ethanone N-oxides. These compounds possess valuable therapeutic potential for the treatment of allergic conditions and hyperacidity. The patent discloses multiple variations of the compound, allowing for flexibility and further exploration in pharmacological applications.
Career Highlights:
Throughout his illustrious career, VON Strandtmann has made substantial strides in the field of pharmaceuticals. His innovative patents have undoubtedly contributed to advancements in healthcare and treatment options. Notably, he has worked with reputable organizations such as Warner-Lambert Company, which is known for its contributions to the pharmaceutical industry. His association with such esteemed companies speaks volumes about his capabilities and expertise in the field of pharmaceutical research.
Collaborations:
VON Strandtmann has had the privilege of collaborating with exceptional minds in his field. Notable among his coworkers are David T. Connor and Patricia A. Young. These collaborations have fostered an environment of exchange and collaboration, leading to the development of groundbreaking inventions and patents. The power of teamwork and collective intelligence is evident in VON Strandtmann's collaborative efforts.
Conclusion:
Maximilian VON Strandtmann's journey as an inventor has been marked by a series of remarkable achievements. With his 20 patents, he has contributed significantly to the advancement of pharmaceutical research and development. His latest patents in the fields of antifungal agents and therapeutic compounds demonstrate his ability to address critical medical needs. In addition, his collaborations with esteemed colleagues have further enriched his work in the pursuit of groundbreaking innovations. VON Strandtmann's dedication and ingenuity exemplify the essence of the inventors and innovators celebrated on iDIYas.com, inspiring others to strive for excellence in the world of patents and inventions.